Lycopodium Limited provided earnings guidance for second half and full year of 2020. It is expected the second half of the year will be softer, due to the timing of new projects commencing and anticipated delays impacting revenue. On this basis, the Company provides guidance for the full year of approximately $220 million in revenue and NPAT of $14.1 million. The Coronavirus is noted as a developing issue beyond the Company's control, with any potential impact not taken into consideration in the full year guidance.